Biotech News

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

Treace Medical Concepts (TMCI)Treace Medical ConceptsEarnings

PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release

Open original release

Related news

Treace Medical Concepts

Treace Medical Concepts is a foot-and-ankle surgical device company known for its Lapiplasty system. Its story revolves around procedural adoption and expanding surgeon usage.

Recent company news

Stock data

Close
4.08 USD
Market cap
225.11M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States